The Effect of Needle Placement on Muscle Stiffness, Gait, Balance, Pain and Functional Outcomes in Individuals With Injury to the Ankle and/or Hindfoot

October 6, 2023 updated by: Stephanie Albin, Regis University

The Effect of Needle Placement on Muscle Stiffness, Gait, Balance, Pain and Functional

The purpose of this randomized controlled trial is to assess the effect of DN at either the site of the identified myofascial trigger point/s (MTrP) of in the same muscle, but away from the MTrP site/s in individuals with ankle and/or hindfoot injury. Assessments will be of self-reported outcomes, self-reported pain, gait, balance, muscle stiffness, and pain pressure threshold. The secondary purpose of this study is to determine the validity of dry needling specific muscles of the lower extremity based upon needle placement, location relative to anatomical structures and accuracy of needle placement in muscle using ultrasound imaging.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Few studies have assessed the validity of needling muscles of the lower extremity. For muscles such as the tibialis posterior that are not easily accessible or directly palpable secondary to the deep anatomical position and due to the proximity of the tibial nerve and the posterior tibial artery within the deep compartment, examining accurate needle placement is clinically relevant. In addition, DN has been shown to be a beneficial management strategy for individuals with lower extremity condition; however, the investigators may be able to optimize these beneficial effects by performing DN on the MTrP versus other sites within the same muscle.

If needling directly into the MTrP is more effective than needling away from the MTrP but into the same muscle, it is possible that the improved efficiency could help to optimize management of patients with injury to the ankle/hindfoot with less visits and potentially decreasing health care costs.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80221
        • Regis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants with a previous lower extremity injury occurring to the ankle and/or hindfoot within the previous 12 months AND
  • pain greater than 3 out of 10 on the numeric pain rating scale (NPRS) OR
  • limited weightbearing dorsiflexion range of motion of greater than 2.0 cm side-to-side difference as measured by the ankle lunge test (ALT) OR
  • greater than 3.5% side-to-side difference as assessed by the Y-balance test.

Exclusion Criteria:

  • Operative fixation within the past 3 months to the lower extremity
  • Have received DN of the lower extremity within the past 30 days
  • Current pregnancy
  • Have a history of systemic disorders in which DN would be contraindicated (bleeding disorders or current anticoagulant medication use)
  • Immunocompromised
  • Decline participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry Needling within the Myofascial Trigger Point
Randomized to receive DN at the site of the MTrP
The dry-needling treatment will consist of inserting a sterile needle into 2-4 muscles of the participant either at the MTrP or 2 cm away from the MTrP, but within the same muscle. To assist in the reduction of infection risk and protection of the participants, the site will be cleaned with alcohol prior to treatment and investigators performing the needling treatment will wear gloves and handle needles using aseptic technique throughout the procedure. Each needle insertion will last approximately 5 seconds using a "pistoning" (in and out) technique.
Active Comparator: Dry Needling away from Myofascial Trigger Point Site
Randomized to receive DN 2 cm away from the site of the MTrP but within the same muscle
The dry-needling treatment will consist of inserting a sterile needle into 2-4 muscles of the participant either at the MTrP or 2 cm away from the MTrP, but within the same muscle. To assist in the reduction of infection risk and protection of the participants, the site will be cleaned with alcohol prior to treatment and investigators performing the needling treatment will wear gloves and handle needles using aseptic technique throughout the procedure. Each needle insertion will last approximately 5 seconds using a "pistoning" (in and out) technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DN location effect on self-reported and clinical outcomes
Time Frame: 2 year
Foot and Ankle Ability Measure (FAAM)
2 year
DN location effect on clinical outcomes - Muscle Stiffness
Time Frame: 2 year
Muscle Stiffness Measured with the MyotonPro
2 year
DN location effect on clinical outcomes - Gait
Time Frame: 2 year
Plantar pressure during gait measured by the EMED system and GAITRite
2 year
DN location effect on clinical outcomes - Dynamic Balance
Time Frame: 2 year
Balance measured by the Y-balance test
2 year
DN location effect on clinical outcomes - PPT
Time Frame: 2 year
Pain pressure threshold measured by an algometer
2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validation of needle placement in lower extremity muscles
Time Frame: 6 month
Individuals will receive dry needling with the aseptic technique previously described. With the needle in place, diagnostic ultrasound will be performed. The accuracy of the needle placement will be assessed and the distance from the needle to major arteries, nerve, and veins will be measured in millimeters and documented. Only one visit lasting approximately 30 minutes will be required for this portion of the study.
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie Albin, Regis University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

September 1, 2023

Study Registration Dates

First Submitted

July 14, 2020

First Submitted That Met QC Criteria

July 22, 2020

First Posted (Actual)

July 27, 2020

Study Record Updates

Last Update Posted (Estimated)

October 10, 2023

Last Update Submitted That Met QC Criteria

October 6, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • albin2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle and or Hindfoot Injury

Clinical Trials on Dry Needling

Subscribe